Henry D. Coleman has been in patent practice since 1985, with an emphasis on work in high technology chemistry, pharmaceuticals, biotechnology, polymers, cosmetics, and medical devices and instrumentation.

Education: Dr. Coleman graduated from the State University of New York at Buffalo in 1977 with a B.S. in Pharmaceutical/Medicinal Chemistry (magna cum laude) and a B.A. in Political Science (magna cum laude), and in 1982 with a Ph.D. in Pharmaceutical/Medicinal Chemistry. Dr. Coleman attended the University of Wisconsin School of Law, graduating in 1985 (cum laude).

Legal Experience: Dr. Coleman has been engaged as a partner in intellectual property practice since 1987. He has over 20 years of experience in patent procurement and related proceedings, including interferences, before the United States Patent and Trademark Office in a variety of chemical, pharmaceutical, biotechnological and cosmetic technologies. He has extensive experience in patent prosecution with an emphasis on patent procurement in the pharmaceutical and biotechnology arts. He also has extensive negotiating and licensing experience in technology transfer and joint venture research relationships, having negotiated agreements in the areas of cosmetics, pharmaceuticals, biotechnology, medical devices, contact lenses, polymer coatings, paint strippers, printing technology and related products. Dr. Coleman has patent and contract litigation experience (including arbitration experience) in the technical areas of contact lens copolymers, specialty chemicals, cosmetics and pharmaceuticals. Dr. Coleman also has extensive experience in conducting due diligence for freedom to operate opinions and license valuations and providing opinions on patent matters for SEC filings and related financial offerings. Dr. Coleman has been counsel in interference proceedings in the U.S. Patent and Trademark Office in the biotechnology and pharmaceutical arts.

Dr. Coleman was a summer associate (1984) with the Boston patent law firm Fish & Richardson and was an associate attorney with Kenyon & Kenyon from 1985 to 1987. Dr. Coleman was also a partner in the firm McAulay Fisher Nissen Goldberg & Kiel, LLP from 1996-1997 where he practiced intellectual property law primarily in the chemical and pharmaceutical areas.

Dr. Coleman is admitted to practice before the United States Patent and Trademark Office, the United States District Courts for the District of New Jersey, the Southern District of New York and the Eastern District of New York and before the Appellate Courts of the States of New York and New Jersey.

Related Experience: Dr. Coleman has served as a patent expert witness (Life Extension, June 2005) in an arbitration involving nutritional supplements, as a patent expert witness (Hamman & Benn, Chicago, Ill., 1995 1997) in a pharmaceutical patent infringement litigation as well as an expert witness (Habush, Habush & Davis, Madison, Wisconsin l984 85) in a medical malpractice case involving the pharmacological effects of drug combinations on the vitality of a human fetus (wrongful death).

Technical Experience: Dr. Coleman has done graduate research in synthetic organic chemistry (nucleoside, carbohydrate, and heterocyclic), bio organic chemistry (RNA and DNA phosphodiester and phosphotriester chemistry), biochemistry/pharmacology (RNA and DNA biochemistry, modified polymeric nucleoside cell uptake studies, cell culture techniques, and RNA and DNA purification), and drug design (design of anti neoplastic DNA and RNA probes modified with unnatural nucleoside analogs for inhibition of reverse transcriptase and neoplasia). His Ph.D. thesis, "Studies on the Chemical Synthesis of Oligoribonucleotides Containing 5 Mercaptopyrimidine Bases", dealt with research on the design and chemical synthesis of modified deoxyribonucleic acid and ribonucleic acid.

Dr. Coleman has experience in polymer research directing the development of novel gas permeable contact lens polymers. In the early 1990's, Dr. Coleman served as Director of Polymer Research and Development at Permeable Technologies, Inc., a contact lens manufacturer, where he directed polymer development in the contact lens area in concert with a joint venture research group from E.I. DuPont de Nemours & Company. He was Executive Vice-President of Permeable Technologies in 1992. He is a co inventor of three United States patents in the polymer chemistry area and several patent applications in the pharmaceutical and chemical arts.

Bar Association and Professional Memberships: New Jersey Patent Law Association, New York Patent, Trademark and Copyright Association, Association of University Technology Managers and the American Chemical Society.